Status:
COMPLETED
Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)
Lead Sponsor:
Organon and Co
Conditions:
Psychosis
Eligibility:
All Genders
65+ years
Phase:
PHASE3
Brief Summary
This study evaluates the safety and tolerability of Asenapine in elderly patients with psychosis.
Eligibility Criteria
Inclusion
- Elderly subjects with psychosis
Exclusion
- Have an uncontrolled, unstable clinically significant
- medical condition.
- Have an established diagnosis of dementia
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT00281320
Start Date
February 1 2006
End Date
December 1 2008
Last Update
February 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.